➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
Johnson and Johnson
AstraZeneca
Colorcon

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

KEFZOL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Kefzol patents expire, and what generic alternatives are available?

Kefzol is a drug marketed by Acs Dobfar and Lilly and is included in two NDAs.

The generic ingredient in KEFZOL is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Kefzol

A generic version of KEFZOL was approved as cefazolin sodium by SANDOZ on December 9th, 1988.

  Start Trial

Summary for KEFZOL
Drug patent expirations by year for KEFZOL
Recent Clinical Trials for KEFZOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tianjin Medical University Cancer Institute and HospitalN/A
AO Research FundPhase 4
ZonMw: The Netherlands Organisation for Health Research and DevelopmentPhase 4

See all KEFZOL clinical trials

Synonyms for KEFZOL
27164-46-1
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-, sodium salt
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, monosodium salt (6R-trans)-
AC-13166
AKOS015895533
Ancef
Ancef (TN)
ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
ANCEF IN PLASTIC CONTAINER
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AS-12230
Atirin
BDBM50247885
Biazolina
Bor-Cefazol
C 5020
C-44235
C08098
C14H13N8NaO4S3
CCG-40011
Cefabiozim
Cefacidal
Cefalomicina
Cefamedin
Cefazil
Cefazina
Cefazolin (sodium)
CEFAZOLIN AND DEXTROSE
CEFAZOLIN SODIUM
Cefazolin sodium (JP17/USP)
Cefazolin sodium [USAN:USP:JAN]
Cefazolin sodium salt
Cefazolin sodium salt, 89.1-110.1%
Cefazolin sodium salt, Antibiotic for Culture Media Use Only
cefazolin-sodium
Cefazoline sodium
Cephazolin Sodium
CEZ sodium
CHEBI:3483
CHEMBL1200523
CS-4634
D00905
EINECS 248-278-4
EU-0100274
Firmacef
FLKYBGKDCCEQQM-WYUVZMMLSA-M
Gramaxin
HMS1570C14
HMS1920K07
HMS2091A10
HMS2097C14
HMS2230I22
HMS3260H10
HMS3714C14
HMS500A16
HY-B1078
KS-00000FVS
Lampocef
Lilly 46083
Liviclina
LP00274
MCULE-2075772357
MFCD00056883
MLS000028706
Monosodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Monosodium cefazolin
NCGC00093731-01
NCGC00260959-01
Neofazol
NSC 291561
NSC-291561
Opera_ID_1323
P380M0454Z
Prestwick_975
Q27106104
Recef
s4595
SCHEMBL40735
SK&F-41558
SKF 41558
SMR000058708
Sodium (6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
sodium (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-((5-methyl-1,3,4-thiadiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
sodium 7beta-(1H-tetrazol-1-yl)acetamido-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
sodium 7beta-[2-(1H-tetrazol-1-yl)-acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
sodium 7beta-[2-(1H-tetrazol-1-yl)acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
Sodium cefazolin
Sodium cephazolin
Sodium CEZ
Sodium CEZ; SKF-41558
sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SPECTRUM1500164
ST024775
Totacef
Tox21_500274
UNII-P380M0454Z
Zolicef
Zolin
Zolisint
ZX-AFC000519

US Patents and Regulatory Information for KEFZOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lilly KEFZOL cefazolin sodium INJECTABLE;INJECTION 062557-001 Sep 10, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Moodys
Johnson and Johnson
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.